Through the definitive agreement, TriZetto will become part of Cognizant’s existing healthcare business.
“Healthcare is undergoing structural shifts due to reform, cost pressure and shifting responsibilities between payers and providers. This creates a significant growth opportunity, which TriZetto will help us capture,” said Francisco D’Souza, CEO of Cognizant. “We are excited that the integrated portfolio of capabilities across technology and operations will uniquely position us to help clients drive higher levels of operational efficiency, while re-imagining care for the future.”
The agreement, which is still subject to regulatory approval, is expected to close in the fourth quarter of 2014.
More articles on acquisitions:
Cerner receives FTC approval for Siemens Health Services acquisition, on track to be finalized in 2015
The ink is still drying on 4 of the most interesting deals in healthcare
Argon Medical to acquire US Biopsy
